| Date Filed | Type | Description |
| 01/10/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Bought 1,853,000 shares
@ $2.21, valued at
$4.1M
|
|
| 01/09/2023 |
4
| HICKLIN DANIEL J (See Remarks) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 295,500 options to buy
@ $2.05, valued at
$605.8k
|
|
| 01/09/2023 |
4
| Lubman Ellen (Chief Business Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 86,200 options to buy
@ $2.05, valued at
$176.7k
|
|
| 01/09/2023 |
4
| Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 115,900 options to buy
@ $2.05, valued at
$237.6k
|
|
| 01/09/2023 |
4
| Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 103,600 options to buy
@ $2.05, valued at
$212.4k
|
|
| 01/09/2023 |
4
| Trost Timothy W. (CFO) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 102,800 options to buy
@ $2.05, valued at
$210.7k
|
|
| 01/09/2023 |
4
| Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 93,600 options to buy
@ $2.05, valued at
$191.9k
|
|
| 01/09/2023 |
4
| Isaacs Randi (Chief Medical Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 103,300 options to buy
@ $2.05, valued at
$211.8k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| DiRocco Derek (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 11,600 options to buy
@ $3.43, valued at
$39.8k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 136,000 options to buy
@ $3.43, valued at
$466.5k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Lazarus Alon (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 11,600 options to buy
@ $3.43, valued at
$39.8k
|
|
| 06/03/2022 |
4
| Chatterjee Meeta (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 7,733 options to buy
@ $3.43, valued at
$26.5k
|
|
| 01/18/2022 |
4
| Isaacs Randi (Chief Medical Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 79,516 options to buy
@ $11.55, valued at
$918.4k
|
|
| 01/18/2022 |
4
| Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 70,967 options to buy
@ $11.55, valued at
$819.7k
|
|
| 01/18/2022 |
4
| Trost Timothy W. (CFO) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 65,960 options to buy
@ $11.55, valued at
$761.8k
|
|
| 01/18/2022 |
4
| HICKLIN DANIEL J (See Remarks) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 215,888 options to buy
@ $11.55, valued at
$2.5M
|
|
| 01/18/2022 |
4
| Lubman Ellen (Chief Business Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 51,088 options to buy
@ $11.55, valued at
$590.1k
|
|
| 01/18/2022 |
4
| Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 34,258 options to buy
@ $11.55, valued at
$395.7k
|
|
| 01/14/2022 |
4
| Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 79,516 options to buy
@ $11.55, valued at
$918.4k
Exercised 24,199 options to buy
@ $1.56, valued at
$37.8k
Exercised 15,532 options to buy
@ $4.77, valued at
$74.1k
|
|
| 01/04/2022 |
4
| Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Exercised 14,102 options to buy
@ $1.56, valued at
$22k
|
|
| 12/17/2021 |
4
| Leonard Reid (COO) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Sold 2,865 shares
@ $13.3875, valued at
$38.4k
Sold 135 shares
@ $13.9736, valued at
$1.9k
|
|
| 11/01/2021 |
4
| Chatterjee Meeta (Director) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 23,200 options to buy
@ $15.97, valued at
$370.5k
|
|
| 11/01/2021 |
3
| Chatterjee Meeta (Director) has filed a Form 3 on Werewolf Therapeutics, Inc. |
| 07/02/2021 |
4
| Karunatilake Chulani (Chief Technology Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 272,000 options to buy
@ $19.23, valued at
$5.2M
|
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
3
| Karunatilake Chulani (Chief Technology Officer) has filed a Form 3 on Werewolf Therapeutics, Inc. |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|